Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now displays a 'No longer looking for participants' notice indicating recruitment has closed and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:25:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.5.4 to v3.5.5, signaling a minor maintenance release. No user-facing content or study data are affected.
    Difference
    0.0%
    Check dated 2026-06-05T11:11:36.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The revision number on the page has been updated from v3.5.3 to v3.5.4, indicating a small update to the site’s underlying template or framework rather than a change to study information.
    Difference
    0.0%
    Check dated 2026-05-14T23:01:01.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    No additions or deletions were detected for the page. The content remains unchanged based on the provided changes data.
    Difference
    0.0%
    Check dated 2026-05-07T21:51:10.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3 on the page, indicating a minor administrative update to the page metadata.
    Difference
    0.0%
    Check dated 2026-04-30T16:33:08.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:25:08.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.